- J Emberlin and R Lewis, effect of Nasaleze onsymptoms of hayfever in adults and the differencein the amount of rescue medication used: In this doubleblind placebo controlled study of 100 adult hay feversufferers the amount of rescue medication (including antihistaminesand nasal sprays) used by the placebo groupwas significantly greater than that used by the active(Nasaleze) group. This study has been peer reviewed andpublished in the respected UK Current Medical Researchand Opinion (CMRO) Vol 22. No 2 275-285 2006.
- K Vlahtsis, clinical study of Nasaleze for relief ofallergy symptoms including sneezing, runny nose,itchy and watery eyes: All 40 participants in this studywere using a pharmaceutical treatment (decongestants,corticosteroids and anti-histamines) for their hayfever atthe beginning of this study. Participants were asked todiscontinue the use of their pharmaceutical treatments anduse Nasaleze only. After 3 weeks of use 85% of participantsrealized improvement in their allergy symptoms. After 6weeks of use, 90% of participants realized improvementin their symptoms. This study was presented at the PanHellenic Conference of ENT Specialists on 19th March 2004
- P Josling and S Steadman, use of cellulose powderfor the treatment of Seasonal Allergic Rhinitis: In thisopen study of over 100 volunteers the participants wereasked to rate how well Nasaleze performed in comparisonto pharmaceutical products they had taken in the past.Volunteers rated Nasaleze as working more effectively forthem than some of the world’s biggest selling allergy brands,such as UCB Pharma’s Benadryl anti-histamine. This studywas peer reviewed and published in a US publication calledAlternatives in Natural Therapy in July 2003.
- V Aivazis, E Bourli, T Maratou et al, measure of improvement in nasal muco-ciliary clearance and peakinspiratory flow rate (PNIFR) in children with allergicrhinitis: This study involved 100 children with an averageage of 8.2 (but including children as young as 1.5 years)and showed a significant improvement in Nasal MucousClearance (reduced from 39 minutes to 18.15 minutes)and a PNIFR improvement of up to 25.7%. Both theseimprovements were due to Nasaleze aiding the regenerationand normalization of the ciliary’s epithelium. This study waspublished in a leading Greek journal Medical Journal, NeaPediatrica Chronica and was presented at the 2005 EuropeanAcademy of Aerbiology and Clinical Immunology in Munich.
- K Vlahtsis, clinical study of Nasaleze for relief ofallergy symptoms including sneezing, runny nose,itchy and watery eyes: All 40 participants in this studywere using a pharmaceutical treatment (decongestants,corticosteroids and anti-histamines) for their hayfever atthe beginning of this study. Participants were asked todiscontinue the use of their pharmaceutical treatments anduse Nasaleze only. After 3 weeks of use 85% of participantsrealized improvement in their allergy symptoms. After 6weeks of use, 90% of participants realized improvementin their symptoms. This study was presented at the PanHellenic Conference of ENT Specialists on 19th March 2004.
- J Emberlin and R Lewis, effect of Nasaleze onsymptoms of hayfever in adults and the differencein the amount of rescue medication used: In this doubleblind placebo controlled study of 100 adult hay feversufferers the amount of rescue medication (including antihistaminesand nasal sprays) used by the placebo groupwas significantly greater than that used by the active(Nasaleze) group. This study has been peer reviewed andpublished in the respected UK Current Medical Researchand Opinion (CMRO) Vol 22. No 2 275-285 2006.
- J Emberlin and R Lewis, efficacy of Nasaleze foruse in hay fever via pollen provocation tests: In thisstudy involving 11 adult hay fever sufferers (diagnosed tobe allergic to grass pollen by skin prick test and history ofhayfever symptoms over the previous years) Nasaleze wasshown to have significant effectsin reducing symptoms of sneezingand itchy eyes. This study waspresented at the EuropeanAcademy of Allergology and ClinicalImmunology (EAACI) conferencein Vienna, June 2006 by J Emberlinand R Lewis. This study willsubsequently be peer reviewed &submitted for publication in aleading Allergy Journal.
- J Emberlin and R Lewis, double blind placebocontrolled cross over challenge study by nasalprovocation with house dust mite allergen 2006: Theresults show significant differences (p=<0.05) for sneezing,itchy nose, runny nose and ECPs in nasal secretions. The resultswere also significant at this level for peak nasal expiratory andinspiratory flow but there was considerable variation. Theresults for other symptoms were not significantly differentbetween the cellulose powder and the placebo. There were no adverse reactions.The inert cellulose powder can havesignificant effects in reducing some symptoms of persistentrhinitis due to house dust mite allergy. Presented as a Posterat the European Academy of Aerobiology and ClinicalImmunology, Sweden, June 2007
|
Læs her om den udenlandske forskning på gravide 
Engholmgruppen, der netop har lanceret 28 urter som tørekstrakter, søger behandlere og butikker, som vil fungere som Lokalt Urte Center.